Business Standard

S&P 500 hits record on strong jobs report, Pfizer Covid-19 pill cheer

US job growth regains momentum Pfizer jumps after positive Covid-19 antiviral pill data

Wall Street, US stocks, S&P, Dow Jones
Premium

The Dow Jones Industrial Average rose 89.68 points, or 0.25%, to 36,213.91, the S&P 500 gained 5.71 points

Lewis Krauskopf, Devik Jain and Bansari Mayur Kamdar | Reuters
The S&P 500 and Dow rose modestly to record highs on Friday following a strong US jobs report and positive data for Pfizer's experimental pill to fight Covid-19.

But stocks were off their session highs in afternoon trade, with the Nasdaq turning negative, as shares of healthcare and some tech and stay-at-home stocks weighed.

The Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.

A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in